Charlotte R. Bell

590 total citations
3 papers, 350 citations indexed

About

Charlotte R. Bell is a scholar working on Oncology, Immunology and Psychiatry and Mental health. According to data from OpenAlex, Charlotte R. Bell has authored 3 papers receiving a total of 350 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Oncology, 2 papers in Immunology and 2 papers in Psychiatry and Mental health. Recurrent topics in Charlotte R. Bell's work include Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). Charlotte R. Bell is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Immune cells in cancer (2 papers) and Cancer, Stress, Anesthesia, and Immune Response (2 papers). Charlotte R. Bell collaborates with scholars based in United Kingdom, Netherlands and Italy. Charlotte R. Bell's co-authors include Christian P. Bromley, Agrin Moeini, Santiago Zelenay, Eimear Flanagan, Eduardo Bonavita, Shih‐Chieh Chiang, Victoria S. Pelly, Claus Jørgensen, Sudhakar Sahoo and Neil C. Rogers and has published in prestigious journals such as Nature Communications, Immunity and Cancer Discovery.

In The Last Decade

Charlotte R. Bell

3 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Charlotte R. Bell United Kingdom 3 180 174 78 47 43 3 350
Eimear Flanagan United Kingdom 4 185 1.0× 175 1.0× 94 1.2× 48 1.0× 44 1.0× 6 371
Colin Hutton United Kingdom 6 212 1.2× 119 0.7× 184 2.4× 28 0.6× 17 0.4× 9 363
Sylvie Roques France 5 216 1.2× 139 0.8× 153 2.0× 27 0.6× 19 0.4× 8 386
Sofía Bruni Argentina 7 193 1.1× 131 0.8× 130 1.7× 41 0.9× 9 0.2× 13 383
Atefeh Ghahremanloo Iran 9 145 0.8× 81 0.5× 157 2.0× 42 0.9× 9 0.2× 16 361
Anja Schmall Germany 5 152 0.8× 177 1.0× 206 2.6× 114 2.4× 24 0.6× 7 453
Nada S. Aboelella United States 5 75 0.4× 75 0.4× 131 1.7× 49 1.0× 16 0.4× 6 290
Ramin Salehi‐Rad United States 9 182 1.0× 143 0.8× 129 1.7× 72 1.5× 18 0.4× 26 372
Sandipto Sarkar United States 13 114 0.6× 74 0.4× 242 3.1× 33 0.7× 21 0.5× 18 394
Haaglim Cho South Korea 9 136 0.8× 139 0.8× 135 1.7× 23 0.5× 9 0.2× 12 329

Countries citing papers authored by Charlotte R. Bell

Since Specialization
Citations

This map shows the geographic impact of Charlotte R. Bell's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Charlotte R. Bell with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Charlotte R. Bell more than expected).

Fields of papers citing papers by Charlotte R. Bell

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Charlotte R. Bell. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Charlotte R. Bell. The network helps show where Charlotte R. Bell may publish in the future.

Co-authorship network of co-authors of Charlotte R. Bell

This figure shows the co-authorship network connecting the top 25 collaborators of Charlotte R. Bell. A scholar is included among the top collaborators of Charlotte R. Bell based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Charlotte R. Bell. Charlotte R. Bell is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

3 of 3 papers shown
1.
Bell, Charlotte R., Victoria S. Pelly, Agrin Moeini, et al.. (2022). Chemotherapy-induced COX-2 upregulation by cancer cells defines their inflammatory properties and limits the efficacy of chemoimmunotherapy combinations. Nature Communications. 13(1). 2063–2063. 76 indexed citations
2.
Pelly, Victoria S., Agrin Moeini, Lisanne M. Roelofsen, et al.. (2021). Anti-Inflammatory Drugs Remodel the Tumor Immune Environment to Enhance Immune Checkpoint Blockade Efficacy. Cancer Discovery. 11(10). 2602–2619. 117 indexed citations
3.
Bonavita, Eduardo, Christian P. Bromley, Gustav Jonsson, et al.. (2020). Antagonistic Inflammatory Phenotypes Dictate Tumor Fate and Response to Immune Checkpoint Blockade. Immunity. 53(6). 1215–1229.e8. 157 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Eimear Flanagan Breakdown of academic impact, for papers by Colin Hutton Breakdown of academic impact, for papers by Sylvie Roques Breakdown of academic impact, for papers by Sofía Bruni Breakdown of academic impact, for papers by Atefeh Ghahremanloo Breakdown of academic impact, for papers by Anja Schmall Breakdown of academic impact, for papers by Nada S. Aboelella Breakdown of academic impact, for papers by Ramin Salehi‐Rad Breakdown of academic impact, for papers by Sandipto Sarkar Breakdown of academic impact, for papers by Haaglim Cho
Rankless by CCL
2026